Fifth stakeholder forum on the implementation of the new pharmacovigilance legislation

Date: 25/05/2012
Location: European Medicines Agency, London, UK
The objectives of the meeting are to present an update to the implementation process, key feedback from recent consultations, questions and answers on the transitional period, specific considerations for biological medicines and feedback on other topics. Registration by invitation only.



How useful was this page?

Add your rating